A Disintegrin and Metalloprotease 10 Expressions Modulate Potential Metastatic and Thrombus Formation in Pancreatic Carcinoma
Background: Clinical investigations repurposing a disintegrin and metalloproteases 10 (ADAM10) as metastatic and thrombus marker have achieved encouraging results, but the mechanism behind this association remains unclear. Methods: This study was carried out in NingXia and Wuhan, China from 2017...
Main Authors: | Miao Yu, Quan Chen, Qin Li, Yunfei Teng, Lin Xiao, Guang Yang, Chenxi Ouyang, Ahmed Mohammed Elamin Abdalla |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2022-08-01
|
Series: | Iranian Journal of Public Health |
Subjects: | |
Online Access: | https://ijph.tums.ac.ir/index.php/ijph/article/view/27670 |
Similar Items
-
A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
by: Nives Giebeler, et al.
Published: (2016-04-01) -
Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
by: Alexandra L. Matthews, et al.
Published: (2017-05-01) -
A Disintegrin and Metalloprotease 12 Promotes Tumor Progression by Inhibiting Apoptosis in Human Colorectal Cancer
by: Young-Lan Park, et al.
Published: (2021-04-01) -
The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17
by: Yuanpeng Zheng, et al.
Published: (2020-12-01) -
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
by: Marina Fabbi, et al.
Published: (2022-08-01)